EAACI Annual Congress 2025 -outstanding scientific contributions by our scientists and numerous awards for LIH

• Molecular and Translational Allergology
• Department of Infection and Immunity
• Immunological Disorders
• Translational & Clinical Immunology
• Neuro-Immunology Group
• Department of Cancer Research

Luxembourg Institute of Health’s scientists from several research groups presented their latest findings at the 2025 European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress in Glasgow, considered the leading scientific conference on allergic diseases and asthma worldwide with more than 7000 attendants.

Dr. Annette Kuehn and Dr. Christiane Hilger – Group Leaders of the Molecular and Translational Allergology (MTA) Group at the Department of Infection and Immunity – as well as further group members attended this year’s EAACI congress. Both group leaders contributed actively to strategic EAACI task force sessions. Dr. Christiane Hilger gave a lecture on the diagnosis and management of meat allergy and an introductory lecture to molecular allergy diagnosis.

• Postdoctoral Fellow Dr. Noémi Nagy gave an oral presentation on the use of the basophil activation test as a diagnostic tool to further enhance the stratification of peanut allergic-patients.
• MD-PhD student Naphisabet Wanniang presented a poster on low-dose oral food challenges in nut allergic children.
• PhD students Isabela Assugeni and Theresa-Maria Boehm presented their research as posters on the topics of legume sensitization patterns in treenut vs. peanut allergic children and of canine IgE sensitization across Europe in the context of the One Health approach, respectively. Both were rewarded with an outstanding poster presentation award.

Prof. Dr. Markus Ollert – Director of the LIH Department of Infection and Immunity and Group Leader of the Translational and Clinical Immunology (TCI) Group – was honored during the Opening Ceremony of the Congress by EAACI President Prof. Maria Torres with the EAACI Research Fellow Award 2025 in recognition of his professional outstanding achievements and continuous efforts to advance the field of allergy, clinical immunology and asthma. Prof. Ollert contributed to the scientific program of the Congress by an invited talk on “Landscape of the omics in allergy research” and by chairing several scientific sessions. Dr. Murilo Luiz Bazon, postdoctoral fellow in the TCI group of Prof. Ollert, presented a poster entitled: “Tumor Necrosis Factor Receptor 2 (TNFR2) is crucial for the efficacy of Allergen-Specific Immunotherapy in a Pre-Clinical Murine Model”, for which he received an outstanding poster presentation award.

Dr. Aurélie Poli – Senior scientist at the Neuro-Immunology Group within the Department of Cancer Research – delivered a selected talk on the team’s ongoing project exploring immune reprogramming in AllergoOncology as a novel approach for translational research in glioblastoma. This presentation was part of the Late-Breaking Session “Clinical Immunology”. In addition to her oral presentation, Dr. Poli actively contributed to the activities of the AllergoOncology Working Group for the EAACI by chairing the Business Meeting of the STRATALLON Task Force and co-authoring several posters, including one entitled “An EAACI Task Force Scoping Review: Human Monocytes and Macrophages in Allergy – Implications for AllergoOncology”. These contributions underscore the team’s growing leadership and recognition in the field of AllergoOncology, bridging cancer immunology and allergy research.

Funding and collaborations:

Presented research projects were supported by the Luxembourg National Research Fund (FNR) (ImmunoGal C24/BM/18907591, XPOSE PRIDE23/18356118, NEXTIMMUNE PRIDE/11012546, NEXTIMMUNE2 PRIDE21/16749720, i2TRON PRIDE19/14254520, IFAM WEAVE C23/BM/18096599), by the FNR and Fondation Cancer Luxembourg (GRALL C24/BM/18858278); Télévie-FNRS (RESTAGE  7.4576.23), the European Commission’s Horizon Europe program (ALLPreT EU/Horizon/MSCA/101072377, COMMUTE/HORIZON-HLTH-2023-DISEASE-03/10113695, ClimAIr/HORIZON-HLTH-2024-ENVHLTH-02/101156799), and a European Academy of Allergy and Clinical Imunology (EAACI) Long-Term Research Fellowship (2022, MLB).

Collaboration partner: Centre Hospitalier de Luxembourg (CHL).